Diabetes Tech: A Catalyst Rich Sector with a Dazzling Future

Early last year, MD+DI predicted that 2022 would be the biggest year yet for diabetes tech – and we weren't wrong. If the latest news and analyst takeaways from the sector's biggest 2023 conference is any indication, however, we haven't seen anything yet.

Marie Thibault, a medtech analyst at BTIG, said overall attendance at the American Diabetes Association (ADA) 83rd Scientific Sessions seemed low compared to pre-COVID and other medical meetings she's attended this year. However, analyst and investor attendance at ADA was particularly high, she noted in a report Monday.